Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains one of the most challenging diseases to treat, with conventional treatments often causing severe side effects due to their lack of specificity. The development of novel drug delivery systems for targeted cancer therapy has emerged as a promising approach to improve treatment outcomes while minimizing adverse effects. This thesis explores the design, development, and evaluation of innovative drug delivery systems tailored for the targeted delivery of anticancer agents to tumor cells. The introduction provides a comprehensive overview of the current landscape of cancer therapy, highlighting the limitations of existing treatment modalities and the need for more targeted and effective approaches. The background of the study delves into the principles of drug delivery systems and their potential applications in oncology. The problem statement underscores the challenges faced in cancer treatment and the rationale for developing targeted drug delivery systems to address these issues. The objectives of the study aim to design and optimize drug delivery systems that can enhance the specificity and efficacy of anticancer drugs, ultimately improving patient outcomes. The limitations of the study are discussed to provide a transparent account of the potential constraints and challenges encountered during the research process. The scope of the study outlines the specific aspects and parameters that will be investigated to achieve the research objectives. The significance of the study emphasizes the potential impact of developing novel drug delivery systems for targeted cancer therapy, including improved treatment outcomes, reduced side effects, and enhanced patient quality of life. The structure of the thesis provides an overview of the organization of the research document, highlighting the key chapters and sections that will be covered in detail. Definitions of key terms are provided to ensure clarity and understanding of the terminology used throughout the thesis. The literature review chapter critically examines existing research and developments in the field of drug delivery systems for cancer therapy. Ten key areas are explored, including the principles of targeted drug delivery, nanotechnology-based drug delivery systems, and the challenges of overcoming drug resistance in cancer treatment. The research methodology chapter details the experimental design, materials, and methods used to develop and evaluate novel drug delivery systems for targeted cancer therapy. Eight key components are discussed, including the selection of drug carriers, formulation optimization, in vitro and in vivo evaluations, and data analysis techniques. The discussion of findings chapter presents the results of the experimental studies, including the characterization of drug delivery systems, drug release profiles, cellular uptake mechanisms, and anticancer efficacy assessments. The implications of the findings are discussed in the context of advancing the field of targeted cancer therapy. In conclusion, this thesis offers a comprehensive overview of the development of novel drug delivery systems for targeted cancer therapy. The summary highlights the key findings, contributions, and future directions for research in this rapidly evolving field, emphasizing the potential of targeted drug delivery systems to revolutionize cancer treatment and improve patient care. Keywords Cancer therapy, drug delivery systems, targeted therapy, nanotechnology, anticancer agents, treatment outcomes.